InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,436.44
(
-0.50%
)
US TECH 100
18,394.40
(
-0.87%
)
Dow Jones
40,743.33
(
0.50%
)
Brent Oil
78.92
(
0.45%
)
Bitcoin
66,142.69
(
-0.04%
)
Post# of 252748
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

xavierprivas

Send PM Follow Ignore
Followers 6
Posts 162
Boards Moderated 0
Alias Born 09/14/2009

xavierprivas

Re: bladerunner1717 post# 203440

Sunday, 08/14/2016 10:59:59 AM

Sunday, August 14, 2016 10:59:59 AM

Post# of 252748
I have not followed ITEK trabodenoson closely for a while so take this with a grain of salt.
Last I remember trabodenoson + latanaprost failed to achieve the level of IOP lowering as Timolol (a beta-blocker) + latanaprost in a p2 study sometime in
early 2015.
Since then they have done anything except raising money.
They had a "positive" end of p2 meeting with FDA July 15 and started p3 last year.
I have doubt as to their chance of success but I could be wrong.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up